SCHEMBL6204275

SCHEMBL6204275

CCOc1ccc2[nH]cc(C(N)=O)c(=O)c2c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 3/20 0.64
KDM4E B2RXH2 7/20 0.64
HSD17B10 Q99714 4/20 0.64
ALDH1A1 P00352 3/20 0.64
HPGD P15428 3/20 0.64
POLB P06746 2/20 0.64
MEN1 O00255 4/20 0.61
KMT2A Q03164 4/20 0.61
GABRA1 P14867 2/20 0.53
GABRB2 P47870 2/20 0.53
SMN1; SMN2 Q16637 4/20 0.53
GABRB1 P18505 1/20 0.52
GABRA3 P34903 1/20 0.52
LMNA P02545 2/20 0.52
MAPT P10636 1/20 0.52
TDP1 Q9NUW8 1/20 0.52
TP53 P04637 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
RXFP1 Q9HBX9 1/20 0.51
NPC1 O15118 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2010976 0.88 HTT (0.81) HTTKDM4EHSD17B10ALDH1A1HPGD
SCHEMBL3477919 0.85 KDM4E (0.64) HTTKDM4EHSD17B10ALDH1A1HPGD
SCHEMBL21547894 0.83 KDM4E (0.53) HTTKDM4EHSD17B10ALDH1A1HPGD
SCHEMBL17429435 0.82 HTT (0.67) HTTKDM4EHSD17B10ALDH1A1HPGD
SCHEMBL7740429 0.82 KDM4E (0.78) HTTKDM4EHSD17B10ALDH1A1HPGD
SCHEMBL7738709 0.80 HSD17B10 (0.73) HTTKDM4EHSD17B10ALDH1A1HPGD
SCHEMBL6204810 0.80 POLB (0.88) HTTKDM4EHSD17B10ALDH1A1HPGD
SCHEMBL7738707 0.80 POLB (0.70) HTTKDM4EHSD17B10ALDH1A1HPGD
SCHEMBL7738722 0.79 KDM4E (0.81) HTTKDM4EHSD17B10ALDH1A1HPGD
SCHEMBL6205462 0.78 POLB (0.62) HTTKDM4EHSD17B10ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1177177-B1 SUBSTITUTED 4-OXO-QUINOLINE-3-CARBOXAMIDES: GABA BRAIN RECEPTOR LIGANDS NEUROGEN CORP (US) 2005-02-23 EP claimed
US-6413956-B1 AGONISTS, ANTAGONISTS OR INVERSE AGONISTS AND LOCALIZATION PROBES FOR GAMMA AMINOBUTYRIC ACID BRAIN RECEPTORS; ANXIETY, DEPRESSION, DOWN SYNDROME, SLEEP AND SEIZURE DISORDERS, OVERDOSE WITH BENZODIAZEPINE DRUGS AND MEMORY ENHANCEMENT NEUROGEN CORPORATION 2002-07-02 US claimed
EP-1177177-B1 SUBSTITUTED 4-OXO-QUINOLINE-3-CARBOXAMIDES: GABA BRAIN RECEPTOR LIGANDS NEUROGEN CORP (US) 2005-02-23 EP disclosed
US-6413956-B1 AGONISTS, ANTAGONISTS OR INVERSE AGONISTS AND LOCALIZATION PROBES FOR GAMMA AMINOBUTYRIC ACID BRAIN RECEPTORS; ANXIETY, DEPRESSION, DOWN SYNDROME, SLEEP AND SEIZURE DISORDERS, OVERDOSE WITH BENZODIAZEPINE DRUGS AND MEMORY ENHANCEMENT NEUROGEN CORPORATION 2002-07-02 US disclosed